Rezultati

eNauka >  Results >  A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIa clinical trial
Title: A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg plus chronic hepatitis B - a phase IIa clinical trial
Authors: Schneider, J.; Halota, W.; Delić, Dragan; Nešić, Zorica  ; Prokopowicz, D.; Flisiak, R.; Kuydowicz, J.; Jablkowski, M.; Cianciara, J.; Mach, T.;
Issue Date: 2006
Publication: Journal of hepatology
ISSN: 0168-8278 Journal of Hepatology Search Idenfier
Publisher: Amsterdam : Elsevier
Type: Conference Paper
Collation: vol. 44 br. Vol. 44 str. S277-S278
DOI: 10.1016/S0168-8278(06)80750-6
WoS-ID: 000237328100750
VBS COBISS: 1026581173
URI: https://plus.cobiss.net/cobiss/sr/sr/bib/1026581173#izum.si
https://enauka.gov.rs/handle/123456789/663397
M-category: 
Mp. category will be shown later

1
OpenCitations
1
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.